D027 Alzheimer’s Disease (AD) Final Synthesis: Understanding Key Aspects

Student Name

Western Governors University

D027 Advanced Pathopharmacological Foundations

Prof. Name:

Date

Alzheimer’s Disease Synthesis

What is Alzheimer’s Disease?

Alzheimer’s Disease is a progressive neurological disorder that primarily impairs memory, thinking, and reasoning skills. It is recognized as the most prevalent form of dementia, accounting for approximately 60% to 80% of dementia cases globally. In the United States, Alzheimer’s ranks as the seventh leading cause of death, highlighting its significant impact on public health (National Institutes of Health [NIH], 2021).

What Causes Alzheimer’s Disease? (Pathophysiology)

The precise cause of Alzheimer’s Disease remains unclear. However, it is believed to result from a complex interplay of genetic predispositions, environmental exposures, and lifestyle factors. Key pathological features include the formation of extracellular beta-amyloid plaques—clusters of protein fragments accumulating outside neurons—and intracellular neurofibrillary tangles made of tau protein (NIH, 2021).

These abnormalities disrupt normal neuronal function, leading to synaptic loss, neuronal death, and deficits in critical neurotransmitters such as acetylcholine. Consequently, brain regions responsible for memory and cognition undergo significant atrophy. Moreover, chronic neuroinflammation and the brain’s immune response further contribute to the acceleration of plaque and tangle formation, exacerbating neurodegeneration and clinical decline.

What are the Clinical Manifestations of Alzheimer’s Disease?

Alzheimer’s Disease progresses slowly and can be categorized into three stages: mild (early), moderate, and severe (late stage). The disease is often preceded by a set of ten hallmark warning signs, which help in early identification:

Warning Sign Number	Symptom Description
1	Memory loss that disrupts daily life
2	Difficulties with planning and problem-solving
3	Trouble completing familiar tasks
4	Confusion about time or place
5	Problems with visual perception and spatial relations
6	New difficulties in speaking or writing
7	Misplacing items and inability to retrace steps
8	Poor or decreased judgment
9	Withdrawal from work or social activities
10	Changes in mood and personality

The progression through these stages typically spans several years, with an average life expectancy after diagnosis ranging from four to eight years. However, some individuals may live for up to twenty years post-diagnosis, depending on various factors such as overall health and care quality.

Risk factors for Alzheimer’s include advanced age, a history of traumatic brain injury, hypertension (HTN), diabetes, obesity, and smoking. Epidemiologically, women are more likely to develop the disease compared to men, and African Americans face approximately double the risk relative to other racial groups.

How is Alzheimer’s Disease Diagnosed?

Diagnosis of Alzheimer’s Disease involves a comprehensive clinical evaluation that includes reviewing the patient’s medical history, lifestyle habits, and behavioral changes. Cognitive assessments test memory, problem-solving abilities, attention span, language skills, and counting. These tests help differentiate Alzheimer’s from other types of dementia or cognitive impairments.

Additional diagnostic tools include blood and urine tests to exclude other causes of cognitive decline and neuroimaging techniques such as computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET) scans. These imaging modalities assist in detecting brain atrophy and amyloid plaque deposits, confirming the diagnosis (NIH, 2021).

References

National Institutes of Health. (2021). Alzheimer’s disease fact sheet. https://www.nia.nih.gov/health/alzheimers-disease-fact-sheet

Western Governors University. (n.d.). Alzheimer’s disease. Panopto. https://wgu.hosted.panopto.com/Panopto/Pages/Viewer.aspx?id=f280f008-5d8e-42b3-8f7ead8a00f1a105